{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T03:56:27Z","timestamp":1761623787289,"version":"build-2065373602"},"reference-count":127,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"vor","delay-in-days":2317,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas (English Edition)"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.adengl.2013.11.004","type":"journal-article","created":{"date-parts":[[2014,4,13]],"date-time":"2014-04-13T13:45:18Z","timestamp":1397396718000},"page":"378-393","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Spanish Adaptation of the European Guidelines for the Evaluation and Treatment of Actinic Keratosis"],"prefix":"10.1016","volume":"105","author":[{"given":"C.","family":"Ferr\u00e1ndiz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Fonseca-Capdevila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Garc\u00eda-Diez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Guill\u00e9n-Barona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Belinch\u00f3n-Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Redondo-Bell\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.C.","family":"Moreno-Gim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Sen\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.adengl.2013.11.004_bib0005","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1067\/mjd.2000.103342","article-title":"Epidemiology of actinic keratoses and squamous cell carcinoma","volume":"42","author":"Salasche","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.adengl.2013.11.004_bib0010","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1046\/j.1523-1747.2000.00048.x","article-title":"High incidence and regression rates of solar keratoses in a queensland community","volume":"115","author":"Frost","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.adengl.2013.11.004_bib0015","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/bjc.1996.534","article-title":"Non-melanoma skin cancer and solar keratoses. I. Methods and descriptive results of the South Wales Skin Cancer Study","volume":"74","author":"Harvey","year":"1996","journal-title":"Br J Cancer"},{"key":"10.1016\/j.adengl.2013.11.004_bib0020","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000112925","article-title":"Basal cell carcinomas and actinic keratoses seen in dermatological practice in France: A cross-sectional survey","volume":"216","author":"Bernard","year":"2008","journal-title":"Dermatology"},{"key":"10.1016\/j.adengl.2013.11.004_bib0025","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1001\/archderm.142.6.722","article-title":"Prevalence of actinic keratoses and associated factors in a representative sample of the Italian adult population: Results from the Prevalence of Actinic Keratoses Italian Study, 2003-2004","volume":"142","author":"Naldi","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.adengl.2013.11.004_bib0030","first-page":"247","article-title":"Prevalence of cutaneous lesions in Freixo de Espada a Cinta","volume":"13","author":"Massa","year":"2000","journal-title":"Acta Med Port"},{"key":"10.1016\/j.adengl.2013.11.004_bib0035","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1046\/j.1365-2133.2000.03541.x","article-title":"Prevalence of solar damage and actinic keratosis in a Merseyside population","volume":"142","author":"Memon","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.adengl.2013.11.004_bib0040","unstructured":"Stockfleth E, Terhorst D, Braathen L, Cribier B, Cerio R, Ferrandiz C, et al. Guideline on Actinic Keratoses, developed by the Guideline Subcommittee \u00abActinic Keratoses\u00bb of the European Dermatology Forum. 2011 [consultado 3 May 2013]. Disponible en: http:\/\/www.euroderm.org\/images\/stories\/guidelines\/guideline_Management_Actinic_Keratoses-update2011.pdf"},{"key":"10.1016\/j.adengl.2013.11.004_bib0045","unstructured":"Scottish Intercollegiate Guidelines Network. SIGN 50: A guideline developers\u2019 handbook. 2001. Edinburgh: SIGN [consultado 3 May 2013]. Disponible en: http:\/\/www.sign.ac.uk\/guidelines\/fulltext\/50\/index.html"},{"year":"2005","series-title":"Guideline development methods: Information for National Collaborating Centres and Guideline Developers","key":"10.1016\/j.adengl.2013.11.004_bib0050"},{"key":"10.1016\/j.adengl.2013.11.004_bib0055","first-page":"136","article-title":"Sunlight and sunburn in human skin cancer: p53, apoptosis, and tumor promotion","volume":"1","author":"Brash","year":"1996","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1016\/j.adengl.2013.11.004_bib0060","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/00007611-200007000-00001","article-title":"Actinic keratosis is squamous cell carcinoma","volume":"93","author":"Lober","year":"2000","journal-title":"South Med J"},{"key":"10.1016\/j.adengl.2013.11.004_bib0065","first-page":"604","article-title":"Human papillomaviruses in transplant-associated skin cancers","volume":"30","author":"Stockfleth","year":"2004","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.adengl.2013.11.004_bib0070","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1073\/pnas.75.3.1537","article-title":"Characterization of two types of human papillomaviruses in lesions of epidermodysplasia verruciformis","volume":"75","author":"Orth","year":"1978","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.adengl.2013.11.004_bib0075","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/sj.onc.1203339","article-title":"E6 proteins from diverse cutaneous HPV types inhibit apoptosis in response to UV damage","volume":"19","author":"Jackson","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.adengl.2013.11.004_bib0080","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1101\/gad.182100","article-title":"Role of bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteins","volume":"14","author":"Jackson","year":"2000","journal-title":"Genes Dev"},{"key":"10.1016\/j.adengl.2013.11.004_bib0085","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.cell.2012.03.048","article-title":"Multifocal epithelial tumors and field cancerization from loss of mesenchymal CSL signaling","volume":"149","author":"Hu","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.adengl.2013.11.004_bib0090","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1365-2133.2012.11110.x","article-title":"The expression of antimicrobial peptides is significantly altered in cutaneous squamous cell carcinoma and precursor lesions","volume":"167","author":"Scola","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.adengl.2013.11.004_bib0095","first-page":"274","article-title":"Multiple actinic keratosis and skin tumors secondary to hydroxyurea treatment","volume":"196","author":"Salmon-Ehr","year":"1998","journal-title":"Dermatology"},{"key":"10.1016\/j.adengl.2013.11.004_bib0100","first-page":"16","article-title":"Multiple keratosis induced by hydroxyurea","volume":"122","author":"Grange","year":"1995","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.adengl.2013.11.004_bib0105","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0165-1161(94)90015-9","article-title":"Sister-chromatid exchange (SCE) among individuals chronically exposed to arsenic in drinking water","volume":"312","author":"Lerda","year":"1994","journal-title":"Mutat Res"},{"key":"10.1016\/j.adengl.2013.11.004_bib0110","first-page":"1727","article-title":"A genetic explanation of Slaughter's concept of field cancerization: Evidence and clinical implications","volume":"63","author":"Braakhuis","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.adengl.2013.11.004_bib0115","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1001\/archderm.139.9.1216","article-title":"Solar keratosis is squamous cell carcinoma","volume":"139","author":"Ackerman","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.adengl.2013.11.004_bib0120","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1365-2133.2005.07121.x","article-title":"Solar (actinic) keratosis is squamous cell carcinoma","volume":"155","author":"Ackerman","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.adengl.2013.11.004_bib0125","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0190-9622(99)70119-2","article-title":"Cutaneous squamous cell carcinomas consistently show histologic evidence of in situ changes: A clinicopathologic correlation","volume":"41","author":"Guenthner","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.adengl.2013.11.004_bib0130","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/archderm.140.7.813","article-title":"Effect of a 1-week treatment with .5% topical fluorouracil on occurrence of actinic keratosis after cryosurgery: A randomized, vehicle-controlled clinical trial","volume":"140","author":"Jorizzo","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.adengl.2013.11.004_bib0135","first-page":"651","article-title":"Development of a treatment algorithm for actinic keratoses: A European consensus","volume":"18","author":"Stockfleth","year":"2008","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.adengl.2013.11.004_bib0140","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1046\/j.1365-4362.1998.00467.x","article-title":"Frequency of pre-existing actinic keratosis in cutaneous squamous cell carcinoma","volume":"37","author":"Mittelbronn","year":"1998","journal-title":"Int J Dermatol"},{"issue":"Suppl 3","key":"10.1016\/j.adengl.2013.11.004_bib0145","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1365-2133.2007.07860.x","article-title":"Actinic keratosis is an early in situ squamous cell carcinoma: A proposal for reclassification","volume":"156","author":"Rowert-Huber","year":"2007","journal-title":"Br J Dermatol"},{"issue":"Suppl 3","key":"10.1016\/j.adengl.2013.11.004_bib0150","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1365-2133.2007.07865.x","article-title":"Actinic keratoses: Non-invasive diagnosis for field cancerisation","volume":"156","author":"Ulrich","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.adengl.2013.11.004_bib0155","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/978-3-642-59410-6_28","article-title":"Photodynamic therapy and fluorescence diagnosis of skin cancers","volume":"160","author":"Szeimies","year":"2002","journal-title":"Recent Results Cancer Res"},{"key":"10.1016\/j.adengl.2013.11.004_bib0160","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/ijc.2910460303","article-title":"Incidence and determinants of skin cancer in a high-risk Australian population","volume":"46","author":"Green","year":"1990","journal-title":"Int J Cancer"},{"key":"10.1016\/j.adengl.2013.11.004_bib0165","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1177\/120347540200600301","article-title":"The majority of cutaneous squamous cell carcinomas arise in actinic keratoses","volume":"6","author":"Czarnecki","year":"2002","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.adengl.2013.11.004_bib0170","first-page":"335","article-title":"Actinic keratosis: How to differentiate the good from the bad ones?","volume":"16","author":"Quaedvlieg","year":"2006","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.adengl.2013.11.004_bib0175","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1365-2133.1986.tb06644.x","article-title":"Spontaneous remission of solar keratoses: The case for conservative management","volume":"115","author":"Marks","year":"1986","journal-title":"Br J Dermatol"},{"issue":"Suppl 3","key":"10.1016\/j.adengl.2013.11.004_bib0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2133.2007.07861.x","article-title":"Epidemiology of nonmelanoma skin cancer (NMSC) in Europe: Accurate and comparable data are needed for effective public health monitoring and interventions","volume":"156","author":"Trakatelli","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.adengl.2013.11.004_bib0185","first-page":"1099","article-title":"The kinetics of skin cancer: Progression of actinic keratosis to squamous cell carcinoma","volume":"33","author":"Fuchs","year":"2007","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.adengl.2013.11.004_bib0190","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1067\/mjd.2000.103339","article-title":"The risk of progression to invasive disease","volume":"42","author":"Glogau","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.adengl.2013.11.004_bib0195","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1001\/archderm.138.11.1498","article-title":"A randomized, double-blind, vehicle-controlled study to assess 5% imiquimod cream for the treatment of multiple actinic keratoses","volume":"138","author":"Stockfleth","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.adengl.2013.11.004_bib0200","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/s00105-002-0358-4","article-title":"Skin diseases in organ transplant patients","volume":"53","author":"Ulrich","year":"2002","journal-title":"Hautarzt"},{"key":"10.1016\/j.adengl.2013.11.004_bib0205","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00042728-200501000-00009","article-title":"Clinical diagnosis of actinic keratosis identifies an elderly population at high risk of developing skin cancer","volume":"31","author":"Chen","year":"2005","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.adengl.2013.11.004_bib0210","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1093\/ndt\/gfn292","article-title":"Sunscreens in organ transplant patients","volume":"23","author":"Ulrich","year":"2008","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 3","key":"10.1016\/j.adengl.2013.11.004_bib0215","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1365-2133.2009.09453.x","article-title":"Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: A 24 months, prospective, case-control study","volume":"161","author":"Ulrich","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.adengl.2013.11.004_bib0220","first-page":"570","article-title":"Reduced ultraviolet-induced DNA damage and apoptosis in human skin with topical application of a photolyase-containing DNA repair enzyme cream: Clues to skin cancer prevention","volume":"5","author":"Berardesca","year":"2012","journal-title":"Mol Med Report"},{"key":"10.1016\/j.adengl.2013.11.004_bib0225","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1056\/NEJM199310143291602","article-title":"Reduction of solar keratoses by regular sunscreen use","volume":"329","author":"Thompson","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.adengl.2013.11.004_bib0230","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1001\/archderm.139.4.451","article-title":"A randomized controlled trial to assess sunscreen application and beta carotene supplementation in the prevention of solar keratoses","volume":"139","author":"Darlington","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.adengl.2013.11.004_bib0235","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0140-6736(98)12168-2","article-title":"Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: A randomised controlled trial","volume":"354","author":"Green","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.adengl.2013.11.004_bib0240","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1001\/archderm.1995.01690140054008","article-title":"High sun protection factor sunscreens in the suppression of actinic neoplasia","volume":"131","author":"Naylor","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.adengl.2013.11.004_bib0245","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1067\/mjd.2002.119649","article-title":"Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: A prospective, randomized study","volume":"47","author":"Szeimies","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.adengl.2013.11.004_bib0250","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1016\/j.jaad.2011.11.933","article-title":"A randomized pilot comparative study of topical methyl aminolevulinate photodynamic therapy versus imiquimod 5% versus sequential application of both therapies in immunocompetent patients with actinic keratosis: Clinical and histologic outcomes","volume":"66","author":"Serra-Guillen","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.adengl.2013.11.004_bib0255","first-page":"599","article-title":"Guidelines for the management of actinic keratoses","volume":"16","author":"Stockfleth","year":"2006","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.adengl.2013.11.004_bib0260","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1067\/mjd.2000.103338","article-title":"The treatment of actinic keratoses","volume":"42","author":"Dinehart","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.adengl.2013.11.004_bib0265","unstructured":"Dirschka T, Dominicus R, Lars K, Rodriguez R, Willers C, Simon JC. Long term efficacy and recurrence of topical .5% 5-fluorouracil with 10% salicylic acid for actinic keratosis compared to cryotherapy. A prospective, active, controlled, randomized, exploratory study [Poster]. En: 6 th World Meeting of Interdisciplinary Melanoma\/Skin Cancer Centers and 8 th European Association of Derma Oncology Congress. 2012. http:\/\/www.sbc-congresos.com\/pdf2012\/programmelanoma2012.pdf."},{"key":"10.1016\/j.adengl.2013.11.004_bib0270","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0190-9622(82)70143-4","article-title":"Cryosurgery cure rate of actinic keratoses","volume":"7","author":"Lubritz","year":"1982","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.adengl.2013.11.004_bib0275","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1365-4632.2004.02056.x","article-title":"A prospective study of the use of cryosurgery for the treatment of actinic keratoses","volume":"43","author":"Thai","year":"2004","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.adengl.2013.11.004_bib0280","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00105-004-0865-6","article-title":"Cryosurgical treatment of actinic keratoses and evidence-based review","volume":"56","author":"Zouboulis","year":"2005","journal-title":"Hautarzt"},{"key":"10.1016\/j.adengl.2013.11.004_bib0285","unstructured":"Malvehy J, Roldan R, Iglesias P, D\u00edaz A, Puig S. Reflectance confocal microscopy evaluation of the changes induced by the treatment with Solaraze\u00ae (diclofenac 3% in 2.5% hyaluronic acid gel) in the actinic field cancerisation. [Poster] En: 6 thWorld Meeting of Interdisciplinary Melanoma\/Skin Cancer Centers and 8 th European Association of Derma Oncology Congress. 2012. http:\/\/www.sbc-congresos.com\/pdf2012\/program-melanoma2012.pdf."},{"issue":"Suppl 3","key":"10.1016\/j.adengl.2013.11.004_bib0290","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2133.2007.07856.x","article-title":"The role of apoptosis in therapy and prophylaxis of epithelial tumours by nonsteroidal anti-inflammatory drugs (NSAIDs)","volume":"156","author":"Fecker","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.adengl.2013.11.004_bib0295","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1038\/jid.2010.40","article-title":"Enhanced death ligand-induced apoptosis in cutaneous SCC cells by treatment with diclofenac\/hyaluronic acid correlates with downregulation of c-FLIP","volume":"130","author":"Fecker","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.adengl.2013.11.004_bib0300","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1096\/fj.03-0329fje","article-title":"IL-1beta-mediated up-regulation of HIF-1alpha via an NFkappaB\/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis","volume":"17","author":"Jung","year":"2003","journal-title":"FASEB J"},{"issue":"Suppl 3","key":"10.1016\/j.adengl.2013.11.004_bib0305","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1365-2133.2007.07855.x","article-title":"Apoptosis pathways as promising targets for skin cancer therapy","volume":"156","author":"Eberle","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.adengl.2013.11.004_bib0310","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1600-0625.2012.01516.x","article-title":"Activation of mitochondrial apoptosis pathways in cutaneous squamous cell carcinoma cells by diclofenac\/hyaluronic acid is related to upregulation of Bad as well as downregulation of Mcl-1 and Bcl-w","volume":"21","author":"Rodust","year":"2014","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.adengl.2013.11.004_bib0315","first-page":"1011","article-title":"Modes of action of diclofenac 3%\/hyaluronic acid 2.5% in the treatment of actinic keratosis","volume":"9","author":"Maltusch","year":"2014","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.adengl.2013.11.004_bib0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0192-0561(98)00068-X","article-title":"Imiquimod applied topically: A novel immune response modifier and new class of drug","volume":"21","author":"Miller","year":"1999","journal-title":"Int J Immunopharmacol"},{"key":"10.1016\/j.adengl.2013.11.004_bib0325","unstructured":"Zyclara\u00ae, ficha t\u00e9cnica. Agencia Espa\u00f1ola del Medicamento y Productos Sanitarios [acceso 3 May 2013]. Disponible en: http:\/\/www.ema.europa.eu\/docs\/es_ES\/document_library\/EPAR_-_Product_Information\/human\/002387\/WC500132261.pdf"},{"key":"10.1016\/j.adengl.2013.11.004_bib0330","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jaad.2009.06.020","article-title":"Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: Results of two placebo-controlled studies of daily application to the face and balding scalp for two 3-week cycles","volume":"62","author":"Hanke","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.adengl.2013.11.004_bib0335","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jaad.2009.07.004","article-title":"Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: results of two placebo-controlled studies of daily application to the face and balding scalp for two 2-week cycles","volume":"62","author":"Swanson","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.adengl.2013.11.004_bib0340","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1158\/0008-5472.CAN-03-2837","article-title":"Antitumor activity of 3-ingenyl angelate: Plasma membrane and mitochondrial disruption and necrotic cell death","volume":"64","author":"Ogbourne","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.adengl.2013.11.004_bib0345","unstructured":"Picato\u00ae ficha t\u00e9cnica. Agencia Espa\u00f1ola del Medicamento y Productos Sanitarios [acceso 3 May 2013]. Disponible en: http:\/\/www.ema.europa.eu\/docs\/es_ES\/document_library\/EPAR_-_Product_Information\/human\/002275\/WC500135327.pdf"},{"key":"10.1016\/j.adengl.2013.11.004_bib0350","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.4049\/jimmunol.174.3.1259","article-title":"Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8","volume":"174","author":"Gorden","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.adengl.2013.11.004_bib0355","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0140-6736(82)91393-9","article-title":"Etretinate in treatment of actinic keratosis. A double-blind crossover study","volume":"1","author":"Moriarty","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.adengl.2013.11.004_bib0360","first-page":"381","article-title":"Actinic keratoses--surgical and physical therapeutic modalities","volume":"71","author":"Yu","year":"2003","journal-title":"Cutis"},{"key":"10.1016\/j.adengl.2013.11.004_bib0365","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1399-0012.2004.00311.x","article-title":"Acitretin and skin cancer in kidney transplanted patients. Clinical and histological evaluation and immunohistochemical analysis of lymphocytes, natural killer cells and Langerhans\u2019 cells in sun exposed and sun protected skin","volume":"19","author":"Carneiro","year":"2005","journal-title":"Clin Transplant"},{"key":"10.1016\/j.adengl.2013.11.004_bib0370","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/j.1365-2133.2006.07454.x","article-title":"Specialist dermatology clinics for organ transplant recipients significantly improve compliance with photoprotection and levels of skin cancer awareness","volume":"155","author":"Ismail","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.adengl.2013.11.004_bib0375","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/j.1365-2133.2003.05740.x","article-title":"A prospective study of the incidence of skin cancer and its risk factors in a Spanish Mediterranean population of kidney transplant recipients","volume":"149","author":"Fuente","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.adengl.2013.11.004_bib0380","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/0190-9622(95)91276-2","article-title":"Epidermal dysplasia and neoplasia in kidney transplant recipients","volume":"33","author":"Ferrandiz","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.adengl.2013.11.004_bib0385","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0190-9622(92)70164-B","article-title":"Soft tissue reconstruction with skin grafting","volume":"27","author":"Johnson","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.adengl.2013.11.004_bib0390","first-page":"35","article-title":"An update on newer topical therapies for actinic keratoses: Advances and applications","volume":"2","author":"Del Rosso","year":"2003","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.adengl.2013.11.004_bib0395","first-page":"1261","article-title":"Actinic keratoses and the incidence of occult squamous cell carcinoma: A clinical-histopathologic correlation","volume":"32","author":"Ehrig","year":"2006","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.adengl.2013.11.004_bib0400","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/sj.jid.5700264","article-title":"Imiquimod for actinic keratosis: Systematic review and meta-analysis","volume":"126","author":"Hadley","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.adengl.2013.11.004_bib0405","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1365-2133.2006.07616.x","article-title":"Treatment of post-transplant premalignant skin disease: A randomized intrapatient comparative study of 5-fluorouracil cream and topical photodynamic therapy","volume":"156","author":"Perrett","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.adengl.2013.11.004_bib0410","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/0190-9622(92)70144-5","article-title":"Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection","volume":"26","author":"Rowe","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.adengl.2013.11.004_bib0415","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1365-2133.2010.10098.x","article-title":"A randomized comparative study of tolerance and satisfaction in the treatment of actinic keratosis of the face and scalp between 5% imiquimod cream and photodynamic therapy with methyl aminolaevulinate","volume":"164","author":"Serra-Guillen","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.adengl.2013.11.004_bib0420","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0167-8140(87)80017-8","article-title":"Carcinoma of the lip and selected sites of head and neck skin. A clinical study of 896 patients","volume":"8","author":"Petrovich","year":"1987","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adengl.2013.11.004_bib0425","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0738-081X(01)00171-7","article-title":"Cryosurgery in the management of cutaneous malignancies","volume":"19","author":"Graham","year":"2001","journal-title":"Clin Dermatol"},{"issue":"Suppl 2","key":"10.1016\/j.adengl.2013.11.004_bib0430","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2133.2007.08269.x","article-title":"Topical immunomodulation under systemic immunosuppression: Results of a multicentre, randomized, placebo-controlled safety and efficacy study of imiquimod 5% cream for the treatment of actinic keratoses in kidney, heart, and liver transplant patients","volume":"157","author":"Ulrich","year":"2007","journal-title":"Br J Dermatol"},{"issue":"Suppl 3","key":"10.1016\/j.adengl.2013.11.004_bib0435","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-2133.2007.07864.x","article-title":"Treatment of multiple actinic keratoses with topical diclofenac 3% gel in organ transplant recipients: A series of six cases","volume":"156","author":"Ulrich","year":"2007","journal-title":"Br J Dermatol"},{"issue":"Suppl 2","key":"10.1016\/j.adengl.2013.11.004_bib0440","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-2133.2007.08271.x","article-title":"A randomised study of topical 5% imiquimod vs topical 5-fluorouracil vs cryosurgery in immunocompetent patients with actinic keratoses: A comparison of clinical and histological outcomes including 1-year follow-up","volume":"157","author":"Krawtchenko","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.adengl.2013.11.004_bib0445","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1600-0536.2007.01079.x","article-title":"Allergic contact dermatitis because of topical use of 5-fluorouracil (Efudix cream)","volume":"57","author":"Meijer","year":"2007","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.adengl.2013.11.004_bib0450","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S0149-2918(01)80078-3","article-title":"A pharmacokinetic evaluation of .5% and 5% fluorouracil topical cream in patients with actinic keratosis","volume":"23","author":"Levy","year":"2001","journal-title":"Clin Ther"},{"key":"10.1016\/j.adengl.2013.11.004_bib0455","unstructured":"Solaraze\u00ae ficha t\u00e9cnica. Agencia Espa\u00f1ola del Medicamento y Productos Sanitarios [acceso 3 May 2013]. Disponible en: http:\/\/www.aemps.gob.es\/cima\/especialidad.do?metodo=verFichaWordPdf&codigo=73714&formato=pdf&formulario=FICHAS&file=ficha.pdf"},{"key":"10.1016\/j.adengl.2013.11.004_bib0460","first-page":"20","article-title":"Long-term follow up of diclofenac sodium 3% in 2.5% hyaluronic acid gel for actinic keratosis: One-year evaluation","volume":"2","author":"Nelson","year":"2009","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.adengl.2013.11.004_bib0465","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1046\/j.1365-4362.2001.01324.x","article-title":"Topical 3.0% diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses","volume":"40","author":"Wolf","year":"2001","journal-title":"Int J Dermatol"},{"issue":"Suppl 3","key":"10.1016\/j.adengl.2013.11.004_bib0470","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1365-2133.2007.07859.x","article-title":"Does progression from actinic keratosis and Bowen's disease end with treatment: Diclofenac 3% gel, an old drug in a new environment?","volume":"156","author":"Patel","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.adengl.2013.11.004_bib0475","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.0105-1873.2006.0645f.x","article-title":"Photoallergic contact dermatitis from topical diclofenac in Solaraze gel","volume":"54","author":"Kowalzick","year":"2006","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.adengl.2013.11.004_bib0480","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1684\/ejd.2010.1010","article-title":"Results of a randomized, placebo-controlled safety and efficacy study of topical diclofenac 3% gel in organ transplant patients with multiple actinic keratoses","volume":"20","author":"Ulrich","year":"2010","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.adengl.2013.11.004_bib0485","unstructured":"Aldara\u00ae ficha t\u00e9cnica. Agencia Espa\u00f1ola del Medicamento y Productos Sanitarios [acceso 3 May 2013]. Disponible en: http:\/\/www.ema.europa.eu\/docs\/es_ES\/document_library\/EPAR_-_Product_Information\/human\/000179\/WC500023122.pdf"},{"key":"10.1016\/j.adengl.2013.11.004_bib0490","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.jaad.2003.12.010","article-title":"Imiquimod 5% cream for the treatment of actinic keratosis: Results from two phase iii, randomized, double-blind, parallel group, vehicle-controlled trials","volume":"50","author":"Lebwohl","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.adengl.2013.11.004_bib0495","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1001\/archderm.140.12.1542-a","article-title":"Low incidence of new actinic keratoses after topical 5% imiquimod cream treatment: A long-term follow-up study","volume":"140","author":"Stockfleth","year":"2004","journal-title":"Arch Dermatol"},{"issue":"Suppl 2","key":"10.1016\/j.adengl.2013.11.004_bib0500","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-2133.2007.08272.x","article-title":"Multicentre, open-label study using imiquimod 5% cream in one or two 4-week courses of treatment for multiple actinic keratoses on the head","volume":"157","author":"Stockfleth","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.adengl.2013.11.004_bib0505","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1365-2133.2007.07942.x","article-title":"Vehicle-controlled, randomized, double-blind study to assess safety and efficacy of imiquimod 5% cream applied once daily 3 days per week in one or two courses of treatment of actinic keratoses on the head","volume":"157","author":"Alomar","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.adengl.2013.11.004_bib0510","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jaad.2007.01.047","article-title":"Vehicle-controlled, double-blind, randomized study of imiquimod 5% cream applied 3 days per week in one or two courses of treatment for actinic keratoses on the head","volume":"57","author":"Jorizzo","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.adengl.2013.11.004_bib0515","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/00042728-200506000-00008","article-title":"Long-term clinical outcomes following treatment of actinic keratosis with imiquimod 5% cream","volume":"31","author":"Lee","year":"2005","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.adengl.2013.11.004_bib0520","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jaad.2006.06.006","article-title":"Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: An international consensus. International Society for Photodynamic Therapy in Dermatology, 2005","volume":"56","author":"Braathen","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.adengl.2013.11.004_bib0525","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1046\/j.1365-2133.2002.04719.x","article-title":"Guidelines for topical photodynamic therapy: Report of a workshop of the British Photodermatology Group","volume":"146","author":"Morton","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.adengl.2013.11.004_bib0530","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1111\/j.1365-2133.2006.07520.x","article-title":"Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: Phase IV multicentre clinical trial with 12-month follow up","volume":"155","author":"Tschen","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.adengl.2013.11.004_bib0535","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jaad.2005.06.010","article-title":"Efficacy of 3 different light doses in the treatment of actinic keratosis with 5-aminolevulinic acid photodynamic therapy: A randomized, observer-blinded, intrapatient, comparison study","volume":"53","author":"Radakovic-Fijan","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.adengl.2013.11.004_bib0540","first-page":"340","article-title":"Photodynamic therapy in dermatology","volume":"16","author":"Babilas","year":"2006","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.adengl.2013.11.004_bib0545","unstructured":"Metvix\u00ae ficha t\u00e9cnica. Agencia Espa\u00f1ola del Medicamento y Productos Sanitarios [acceso 3 May 2013]. Disponible en: http:\/\/www.aemps.gob.es\/cima\/especialidad.do?metodo=verFichaWordPdf&codigo=64968&formato=pdf&formulario=FICHAS&file=ficha.pdf"},{"key":"10.1016\/j.adengl.2013.11.004_bib0550","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1111\/j.1365-2133.2008.08488.x","article-title":"Multicentre intraindividual randomized trial of topical methyl aminolaevulinate-photodynamic therapy vs cryotherapy for multiple actinic keratoses on the extremities","volume":"158","author":"Kaufmann","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.adengl.2013.11.004_bib0555","first-page":"30","article-title":"The management of actinic keratoses in the United States with topical fluorouracil: A pharmacoeconomic evaluation","volume":"70","author":"Gupta","year":"2002","journal-title":"Cutis"},{"key":"10.1016\/j.adengl.2013.11.004_bib0560","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1001\/archderm.1995.01690140060009","article-title":"A comparison of the efficacy and safety of Jessner's solution and 35% trichloroacetic acid vs 5% fluorouracil in the treatment of widespread facial actinic keratoses","volume":"131","author":"Lawrence","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.adengl.2013.11.004_bib0565","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/120347540500900501","article-title":"Evaluation of the effectiveness of imiquimod and 5-fluorouracil for the treatment of actinic keratosis: Critical review and meta-analysis of efficacy studies","volume":"9","author":"Gupta","year":"2005","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.adengl.2013.11.004_bib0570","doi-asserted-by":"crossref","first-page":"939","DOI":"10.2217\/imt.12.93","article-title":"Randomized, vehicle-controlled trials of topical 5-fluorouracil therapy for actinic keratosis treatment: An overview","volume":"4","author":"Rhavar","year":"2014","journal-title":"Immunotherapy"},{"key":"10.1016\/j.adengl.2013.11.004_bib0575","first-page":"2006","article-title":"Life-threatening toxicity in a dihydropyrimidine dehydrogenase-deficient patient after treatment with topical 5-fluorouracil","volume":"5","author":"Johnson","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.adengl.2013.11.004_bib0580","unstructured":"Actikerall\u00ae ficha t\u00e9cnica. Agencia Espa\u00f1ola del Medicamento y Productos Sanitarios [acceso 3 May 2013]. Disponible en: http:\/\/www.aemps.gob.es\/cima\/especialidad.do?metodo=verFichaWordPdf&codigo=77675&formato=pdf&formulario=FICHAS&file=ficha.pdf"},{"key":"10.1016\/j.adengl.2013.11.004_bib0585","first-page":"174","article-title":"Topical treatment of actinic keratoses with low-dose 5-fluorouracil in combination with salicylic acid--pilot study","volume":"8","author":"Schlaak","year":"2014","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.adengl.2013.11.004_bib0590","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1056\/NEJMoa1111170","article-title":"Ingenol mebutate gel for actinic keratosis","volume":"366","author":"Lebwohl","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.adengl.2013.11.004_bib0595","unstructured":"Ingenol mebutate gel for actinic keratosis-First line National Institute for Health Research (NIHR)-National Horizon Scanning Centre Company Publication; 2010."},{"key":"10.1016\/j.adengl.2013.11.004_bib0600","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1001\/jamadermatol.2013.2766","article-title":"Long-term follow-up study of ingenol mebutate gel for the treatment of actinic keratoses","volume":"149","author":"Lebwohl","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.adengl.2013.11.004_bib0605","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1365-2133.2008.08615.x","article-title":"A phase ii dose-ranging study of topical resiquimod to treat actinic keratosis","volume":"159","author":"Szeimies","year":"2008","journal-title":"Br J Dermatol"},{"issue":"Suppl","key":"10.1016\/j.adengl.2013.11.004_bib0610","first-page":"1","article-title":"Actinic keratoses: Sequelae and treatments. Recommendations from a consensus panel","volume":"55","author":"Berman","year":"2006","journal-title":"J Fam Pract"},{"key":"10.1016\/j.adengl.2013.11.004_bib0615","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/j.1468-3083.2008.02579.x","article-title":"Actinic keratosis: An occupational and environmental disorder","volume":"22","author":"Schwartz","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.adengl.2013.11.004_bib0620","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1590\/S0365-05962012000300012","article-title":"Actinic keratosis: A clinical and epidemiological revision","volume":"87","author":"Schmitt","year":"2014","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.adengl.2013.11.004_bib0625","first-page":"s45","article-title":"Actinic keratoses: Past, present and future","volume":"9","author":"Fenske","year":"2014","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.adengl.2013.11.004_bib0630","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1093\/jnci\/81.24.1910","article-title":"Quantitative carcinogenesis in man: Solar ultraviolet B dose dependence of skin cancer in Maryland watermen","volume":"81","author":"Strickland","year":"1989","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.adengl.2013.11.004_bib0635","first-page":"25","article-title":"Evaluation of the prognostic significance of follicular extension in actinic keratoses","volume":"5","author":"Pandey","year":"2014","journal-title":"J Clin Aesthet Dermatol"}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1578219014000821?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1578219014000821?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T03:54:07Z","timestamp":1761623647000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1578219014000821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":127,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S1578219014000821"],"URL":"https:\/\/doi.org\/10.1016\/j.adengl.2013.11.004","relation":{},"ISSN":["1578-2190"],"issn-type":[{"type":"print","value":"1578-2190"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spanish Adaptation of the European Guidelines for the Evaluation and Treatment of Actinic Keratosis","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.adengl.2013.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Espa\u00f1a, S.L. and AEDV. All rights reserved.","name":"copyright","label":"Copyright"}]}}